MedTrace Logo

Implantable Cardiac Defibrillators for the Prevention of Sudden Death in Patients With Cardiac Sarcoidosis

NCT01013311 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2023-06-05

No results posted yet for this study

Summary

The purpose of this study is to identify patients with cardiac sarcoidosis who may be at risk for sudden death.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Kenneth A Ellenbogen, MD · Virginia Commonweath University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01013311 on ClinicalTrials.gov